Epikast
Brooklyn, US · Founded 2022 · Delaware corporation · 3 known investors
Find your way into Epikast
Epikast provides AI-powered tools for medical science liaisons and field teams to analyze clinical interactions with physicians and patients, and to access synthesized scientific information in their disease areas. The company serves pharmaceutical and life sciences companies seeking to enhance communication and relationship management with healthcare professionals.
Founders & leadership
EV
Evangelos VergetisNamed on SEC filing
Board
ON
BP
Brad ProsekBoard director
SP
Stelios PapadopoulosBoard director
DK
Daphne KarydasBoard director
AT
Alexandros TzoukasBoard director
DP
Dimitrios PapalexopoulosBoard director
Investors · 3
Also in the syndicate · 1
Kos Biotechnology Partnerslead
Reported raises · per SEC filings
Form D private placements$5.7M disclosed across 2 rounds · 2023–2026
▶$700KraisedFeb 2026 · 2 investors · Other Health CareRule 506(b)
▶$700KraisedFeb 2026 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brad ProsekDirector
- Evangelos VergetisExecutive Officer, Director
- Oleg NodelmanDirector
- Stelios PapadopoulosDirector
- Daphne KarydasDirector
- Alexandros TzoukasDirector
- Dimitrios PapalexopoulosDirector
- Offering amount
- $2.2M
- Amount sold
- $700K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$5MraisedFeb 2023 · 2 investors · Other Health CareRule 506(b)
▶$5MraisedFeb 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Evangelos VergetisExecutive Officer, Director
- Stelios PapadopoulosDirector
- Offering amount
- $10M
- Amount sold
- $5M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Epikast do?
- Epikast provides AI-powered tools for medical science liaisons and field teams to analyze clinical interactions with physicians and patients, and to access synthesized scientific information in their disease areas. The company serves pharmaceutical and life sciences companies seeking to enhance communication and relationship management with healthcare professionals.
- Who are Epikast's investors?
- Epikast's investors include EcoR1 Capital, Vedanta Capital.
- How much funding has Epikast raised?
- Epikast has disclosed $5.7M raised across 2 rounds.
- Where is Epikast headquartered?
- Epikast is headquartered in Brooklyn, US.